References
- Levine R J, Maynard S E, Qian C, et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 2004; 350: 672–683
- Sibai B M. Diagnosis and management of gestational hypertension and preeclampsia. Obstet Gynecol 2003; 102: 181–92
- O'Brien W, Krammer J, O'Leary T. The effect of acetaminophen on prostacyclin production in pregnant women. Am J Obstet Gynecol 1993; 168: 1164–1169
- Lee Y, Hyungsuk K, Brahim J, et al. Aceteminiphen selectively suppresses peripheral prostaglandin E2 release and increases COX-2 gene expression in a clinical model of acute inflammation. Pain 2007; 129: 279–286
- Aronoff D M, Oates J A, Boutaud O. New insights into the mechanism of action of acetaminophen: its clinical pharmacologic characteristics reflect its inhibition of the two prostaglandin H2 synthases. Clin Pharm Therapeutics 2006; 79: 9–19
- Boutaud O, Aronoff D M, Richardson J H, et al. Determinants of the cellular specificity of acetaminophen as an inhibitor of prostaglandin H2 synthases. Proc Natl Acad Sci USA 2002; 99: 7130–7135